Dose-dense ABVD First Line Therapy in Early Stage Unfavorable Hodgkin's Lymphoma
Clinical trial NCT02247869 · COMPLETED
Trial details
- NCT number
- NCT02247869
- Sponsor
- Fondazione Italiana Linfomi - ETS
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2015-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.